| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.069 | 0.2 |